News | March 09, 2008

Good Psychosocial State Post-Arrhythmic Event Halves Death Rate

March 7, 2008 – An individual’s physical health, psychological stress, social support and own sense of well-being, are all factors that can play a significant role in the likelihood of surviving an arrhythmic event, according to a study published in the March 2008 edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society.

The research identifies the link between an individual’s state of mind and physical health may be stronger than many expect. Researchers have found a direct connection between a recovering patient’s psychosocial state and survival rate following an arrhythmic event. While many studies have linked state of mind to the likelihood of a cardiac event occurring, this is the first study to show how a patient’s negative state of mind can have a direct impact on long-term survival after a cardiac event occurs.

In addition, the study found that in high-risk cardiac patients, psychosocial profiles can also independently predict death, separately from a physical assessment.

“In the days, months and years after a patient has experienced an arrhythmic event, the psychosocial state of that individual may have an impact on the longevity of life or likelihood of life-threatening arrhythmias,” said , led by Jonathan Steinberg, M.D., FACC, chief of the Division of Cardiology, St. Luke’s-Roosevelt Hospital Center, New York. “Our research shows that assessing a patient’s mental well-being, and seeking counseling or therapy when needed, can be a critical factor in a successful recovery.”

The new study examined the results of self-reported quality of life (QoL) questionnaires from Antiarrhythmics Versus Implantable Defibrillators (AVID) trial patients who had experienced cardiac arrest or life-threatening ventricular tachycardia (VT). Upon measuring the survival of patients three years after having an arrhythmic event, the study revealed a 40 percent death rate among the one half of patients with a poor psychosocial condition versus a 20 percent death rate among the other half of patients with a good, or better, psychosocial condition.

In the AVID trial, several QoL instruments were used, including SF-36 subscales (Physical and Mental Component Summaries), patient concerns checklist and quality of life index-cardiac. The AVID trial enrolled 1,016 patients, 740 of whom had baseline data available from at least one of the QoL instruments.

The HeartRhythm Journal organization will be present at the American College of Cardiology's 57th Annual Scientific Session being held March 29 - April 1, 2008, in Chicago, IL.

For more information: www.heartrhythmjournal.org

Related Content

The global, prospective, non-randomized UNTOUCHED study evaluated the safety and efficacy of the Boston Scientific Emblem S-ICD System – the only approved implantable defibrillator without wires touching the heart –  for primary prevention of sudden cardiac death specifically in patients with a left ventricular ejection fraction (LVEF) ≤35 percent, the most common population to be indicated for ICD therapy. #Heartrhythm2020 #HRS20 #HRS2020
News | Implantable Cardioverter Defibrillator (ICD) | May 08, 2020
May 8, 2020 — Final results from the UNTOUCHED study of the Emblem Subcutaneous Implantable Defibrillator (S-ICD) Sys
The Boston Scientific Emblem MRI-safe S-ICD system does not require a transvenous lead, leading to fewer complications with this type of ICD.

The Boston Scientific Emblem MRI-safe S-ICD system does not require a transvenous lead, leading to fewer complications with this type of ICD.

Feature | Implantable Cardioverter Defibrillator (ICD) | May 08, 2020
May 8, 2020 — A new clinical trial is the first to compare the safety and efficacy of subcutaneous implantable cardio
Medtronic Initiates Worldwide Pivotal Study of Extravascular Implantable Cardioverter Defibrillator
News | Implantable Cardioverter Defibrillator (ICD) | October 11, 2019
Medtronic plc announced the start of a worldwide pivotal study evaluating its investigational Extravascular Implantable...
Early ICD Use Prolongs Survival After Coronary Stenting
News | Implantable Cardioverter Defibrillator (ICD) | September 18, 2019
Early use of an implantable cardioverter-defibrillator (ICD) after primary coronary intervention lengthens survival in...
A physician explaining an implantable cardioverter defibrillator (ICD) to a patient. Image courtesy of Biotronik.

A physician explaining an implantable cardioverter defibrillator (ICD) to a patient. Image courtesy of Biotronik.

Feature | Implantable Cardioverter Defibrillator (ICD) | May 24, 2019 | Dave Fornell, Editor
This is a brief overview of updates on...
Emblem Subcutaneous ICD Safe and Effective for Majority of Patients
News | Implantable Cardioverter Defibrillator (ICD) | May 13, 2019
May 13, 2019 — Boston Scientific announced acute results from the UNTOUCHED study evaluating safety and efficacy of t
Medtronic Begins Pilot Study of Investigational Extravascular ICD System
News | Implantable Cardioverter Defibrillator (ICD) | August 09, 2018
Medtronic plc announced the start of a pilot study of its investigational Extravascular Implantable Cardioverter...
ICD Placements Not Meeting Medicare Coverage Criteria Decline After Overuse Investigation Announced
Feature | Implantable Cardioverter Defibrillator (ICD) | July 11, 2018
Placement of implantable cardioverter defibrillators (ICDs) not meeting Centers for Medicare and Medicaid Services (CMS...
New Tool Predicts Benefits and Risks of Implantable Defibrillator for Heart Failure Patients
News | Implantable Cardioverter Defibrillator (ICD) | July 02, 2018
University of Washington (UW) Medicine cardiologists have developed a tool to predict which heart-failure patients...
Real-World Data Demonstrates Success Of Smart Pass Filter on Boston Scientific S-ICD System
News | Implantable Cardioverter Defibrillator (ICD) | May 16, 2018
Boston Scientific announced results from an analysis of the LATITUDE database evaluating the successful reduction of...